Skip to main content
Contact +1 (919) 234-1277

Get 25% off your first bioreagent online order — use code: PROTEOSHOP25
Brand: ProteoGenix

Anti-RBD (Omicron/B.1.1.529) Polyclonal Antibody

  • ARO-A22519-50
  • Validated WB
Clonality:
Polyclonal Antibody

Original price was: $262.00.Current price is: $217.00.

50ug 17% OFF + 217 loyalty points
Size
Clear
  • In Stock
  • Wide range of unique reagents
  • Fast worldwide delivery
Anti-RBD (Omicron/B.1.1.529) Polyclonal Antibody in WB Assay

Anti-RBD (Omicron/B.1.1.529) Polyclonal Antibody

Product name ARO-A22519-100
Delivery condition Blue ice (+4°C)
Delivery lead time in business days 3-5 days if in stock; 3-5 weeks if production needed
Storage condition 4°C for short term (1 week), store at -20°C to -80°C for long term(1 year); Avoid repeated freeze-thaw cycles
Brand ProteoGenix
Clonality Polyclonal Antibody
Protein Name surface glycoprotein [Severe acute respiratory syndrome coronavirus 2], S, N-terminal domain of the S1 subunit of the Spike (S) protein from Severe acute respiratory syndrome coronavirus and related betacoronaviruses in the B lineage; cd21624, trimer interface [polypeptide binding], receptor-binding domain of the S1 subunit of coronavirus spike (S) proteins; cl40478, trimer interface [polypeptide binding], putative receptor binding site [polypeptide binding], receptor binding motif, SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from SARS-CoV-2 (COVID-19) and related betacoronaviruses in the B lineage; cd22378, N-linked glycosylation sites [posttranslational modification], S1/S2 cleavage region, S1/S2 furin cleavage site, fusion peptide, internal fusion peptide, heptad repeat 1 [structural motif], heptad repeat 2 [structural motif]
Product name ARO-A22519-1MG
Delivery condition Blue ice (+4°C)
Delivery lead time in business days 3-5 days if in stock; 3-5 weeks if production needed
Storage condition 4°C for short term (1 week), store at -20°C to -80°C for long term(1 year); Avoid repeated freeze-thaw cycles
Brand ProteoGenix
Clonality Polyclonal Antibody
Protein Name surface glycoprotein [Severe acute respiratory syndrome coronavirus 2], S, N-terminal domain of the S1 subunit of the Spike (S) protein from Severe acute respiratory syndrome coronavirus and related betacoronaviruses in the B lineage; cd21624, trimer interface [polypeptide binding], receptor-binding domain of the S1 subunit of coronavirus spike (S) proteins; cl40478, trimer interface [polypeptide binding], putative receptor binding site [polypeptide binding], receptor binding motif, SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from SARS-CoV-2 (COVID-19) and related betacoronaviruses in the B lineage; cd22378, N-linked glycosylation sites [posttranslational modification], S1/S2 cleavage region, S1/S2 furin cleavage site, fusion peptide, internal fusion peptide, heptad repeat 1 [structural motif], heptad repeat 2 [structural motif]
Product name ARO-A22519-50
Delivery condition Blue ice (+4°C)
Delivery lead time in business days 3-5 days if in stock; 3-5 weeks if production needed
Storage condition 4°C for short term (1 week), store at -20°C to -80°C for long term(1 year); Avoid repeated freeze-thaw cycles
Brand ProteoGenix
Clonality Polyclonal Antibody
Protein Name surface glycoprotein [Severe acute respiratory syndrome coronavirus 2], S, N-terminal domain of the S1 subunit of the Spike (S) protein from Severe acute respiratory syndrome coronavirus and related betacoronaviruses in the B lineage; cd21624, trimer interface [polypeptide binding], receptor-binding domain of the S1 subunit of coronavirus spike (S) proteins; cl40478, trimer interface [polypeptide binding], putative receptor binding site [polypeptide binding], receptor binding motif, SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from SARS-CoV-2 (COVID-19) and related betacoronaviruses in the B lineage; cd22378, N-linked glycosylation sites [posttranslational modification], S1/S2 cleavage region, S1/S2 furin cleavage site, fusion peptide, internal fusion peptide, heptad repeat 1 [structural motif], heptad repeat 2 [structural motif]

Introducing our latest biotech product, the Anti-RBD (Omicron/B.1.1.529) Polyclonal Antibody. This powerful antibody is specifically designed to target the receptor binding domain (RBD) of the Omicron variant of the SARS-CoV-2 virus, also known as B.1.1.529. With its unique properties and high specificity, this antibody is a valuable tool for researchers and scientists studying the Omicron variant and its impact on the ongoing COVID-19 pandemic.

The main function of the Anti-RBD Polyclonal Antibody is to bind to the RBD of the Omicron variant, preventing it from attaching to and infecting host cells. This antibody is produced using advanced biotechnology techniques, ensuring its purity and effectiveness. It has been extensively tested and validated for its ability to specifically target the RBD of the Omicron variant, making it a reliable tool for research purposes.

One of the main applications of this antibody is in the development of diagnostic tests for the Omicron variant. By targeting the RBD, it can accurately detect the presence of the Omicron variant in patient samples. This is crucial in tracking the spread of the variant and implementing effective control measures. Additionally, the Anti-RBD Polyclonal Antibody can also be used in the development of potential treatments and vaccines for the Omicron variant.

In terms of experimental use cases, this antibody has shown promising results in neutralizing the Omicron variant in vitro. This means that it has the potential to be used as a therapeutic agent to treat individuals infected with the Omicron variant. Furthermore, it has also been used in studies to better understand the structure and behavior of the Omicron variant, providing valuable insights for further research.

At [Company Name], we understand the urgency and importance of studying the Omicron variant. That’s why we have developed the Anti-RBD (Omicron/B.1.1.529) Polyclonal Antibody to support researchers and scientists in their efforts to combat this rapidly evolving virus. With its high specificity and reliability, this antibody is a valuable asset in the fight against the Omicron variant.

In conclusion, the Anti-RBD (Omicron/B.1.1.529) Polyclonal Antibody is a cutting-edge biotech product with a specific and crucial role in the study of the Omicron variant. Its function, applications, and experimental use cases make it a valuable tool for researchers and scientists in the field of COVID-19 research. Trust in the power of this antibody to aid in the fight against the Omicron variant. Order now and join the fight against this global threat.

Anti-RBD (Omicron/B.1.1.529) Polyclonal Antibody in WB Assay

Anti-RBD (Omicron/B.1.1.529) Polyclonal Antibody in WB Assay

Anti-RBD (Omicron/B.1.1.529) Polyclonal Antibody can bind to its target in Western Blot Assay as detected on gel analysis.

There are no reviews yet.

Be the first to review “Anti-RBD (Omicron/B.1.1.529) Polyclonal Antibody”

Your email address will not be published. Required fields are marked *

Recently viewed products

Loading recently viewed products…

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products